ERIN DOHERTY to Immunotherapy, Adoptive
This is a "connection" page, showing publications ERIN DOHERTY has written about Immunotherapy, Adoptive.
Connection Strength
0.147
-
Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis. Blood Adv. 2025 Nov 11; 9(21):5489-5500.
Score: 0.147